RxDoctor Payments Data

Debbie Snodgrass

Nurse Practitioner · Corpus Christi, TXNPI 1780175166

Payments from drug & device makers

$13,235in general payments, 2019–2025

Across 732 payments — averaging $18.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$3K
  • Aurinia Pharma U.S., Inc.$2K
  • AbbVie$2K
  • Johnson & Johnson$935
  • Pfizer$897
  • Novartis$681
  • plus $5K from 27 others

What the payments were for

  • Food & beverage$13,06199%
  • Education$1741%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,235 in reported general payments places this provider in the 95th percentile of 5,422 nurse practitioner providers in Texas.

See all nurse practitioner providers in Texas

Most prescribed under Part D

DrugClaimsCost to plans & patients
Enbrel SureclickEtanercept24$215,929
Humira(Cf)Adalimumab12$187,094
Cimzia (2 Pack)Certolizumab Pegol18$172,489
Humira(Cf) PenAdalimumab14$164,047
Xeljanz XrTofacitinib Citrate14$112,778
ActemraTocilizumab17$100,163
BenlystaBelimumab12$57,177
RayosPrednisone13$36,492
Hydroxychloroquine Sulfate318$10,772
Leflunomide142$7,088
Diclofenac Sodium59$5,103
MethotrexateMethotrexate Sodium151$3,615
Celecoxib121$3,067
Prednisone314$1,975
Alendronate Sodium144$966

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieHumira(Cf)$1,589$187,09412 claims
UCB, Inc.Cimzia (2 Pack)$352$172,48918 claims
GSKBenlysta$406$57,17712 claims
AmgenRayos$2,563$36,49213 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 5,422 nurse practitioner providers in Texas.

Other nurse practitioner in Corpus Christi

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →